Buffalo Biodiesel Inc. Signs Contract With Major Biodiesel Manufacturer
29 Abril 2009 - 3:39PM
Marketwired
HydroGenetics, Inc. (PINKSHEETS: HYGN) is pleased to announce today
that on April 4th, 2009 Buffalo Biodiesel Inc. (BBD), a wholly
owned subsidiary of HydroGenetics Inc., entered into a delivery
contract of 750,000 lbs of high quality recycled biodiesel
feedstock with one of the largest biodiesel producers in the North
East.
The company has delivered over half the contract and expects to
deliver the remaining contract ahead of schedule. This one contract
alone will gross BBD $137,000 by the end of April.
CEO Charles Hansen commented, "In this challenging business
environment BBD has demonstrated its ability to show growth month
over month. We are working with some of the top tier Biodiesel
companies in North America and we plan to expand our operations
aggressively."
Buffalo Biodiesel's 2008 unaudited financial statements reflect
$1,750,000 on revenues with approximately $300,000 net profit.
HydroGenetics, Inc. will initiate an audit in order to become a
fully reporting 34 Act company immediately.
BBD has some exciting events upcoming and the company will
continue to update our shareholders as events unfold.
About HydroGenetics, Inc.
HydroGenetics, Inc. is an alternative energy company. The
company's mission is to acquire and develop alternative and "green"
technology companies into revenue producing, profitable businesses,
utilizing investment capital and other resources including
management and strategic planning to increase shareholder value.
HydroGenetics, Inc.'s wholly owned subsidiary, HydroAxis
Technologies, Inc., is currently developing "green hydrogen
generating technology systems for any internal combustion engine,"
which will significantly reduce gasoline consumption in existing
and new vehicles.
Forward-Looking Statements
Statements in this press release relating to plans, strategies,
economic performance and trends, projections of results of specific
activities or investments, and other statements that are not
descriptions of historical facts may be forward-looking statements
within the meaning of the Private Securities Litigation Reform Act
of 1995, Section 27A of the Securities Act of 1933 and Section 21E
of the Securities Exchange Act of 1934. Forward-looking information
is inherently subject to risks and uncertainties, and actual
results could differ materially from those currently anticipated
due to a number of factors, which include but are not limited to,
risk factors inherent in doing business. Forward-looking statements
may be identified by terms such as "may," "will," "should,"
"could," "expects," "plans," "intends," "anticipates," "believes,"
"estimates," "predicts," "forecasts," "potential," or "continue,"
or similar terms or the negative of these terms. Although we
believe that the expectations reflected in the forward-looking
statements are reasonable, we cannot guarantee future results,
levels of activity, performance or achievements. The company has no
obligation to update these forward-looking statements.
Contact: Mark Balbirer 305-573-0821
Hydrogenetics (CE) (USOTC:HYGN)
Gráfica de Acción Histórica
De Feb 2025 a Mar 2025
Hydrogenetics (CE) (USOTC:HYGN)
Gráfica de Acción Histórica
De Mar 2024 a Mar 2025